NASDAQ$CLBT

Cellebrite DI Ltd · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Headline financials

Total Revenue

$65.9M

Previous: $53.2M+23.8%
EPS (adj)

$0.08

Previous: $0.04+84.4%

Revenue & EPS history

Cellebrite · Revenue · Quarterly

$65.9M

Q3 2021+23.8%vs Q3 2020
Beat estimate in 4 of 9 quarters(44%)
ActualEstimate

Revenue by segment

Cellebrite · $76.7M total across 4 segments · Q2 2023

  • Subscription services
    $50.5M+38.6%
  • Term-license
    $16.7M+24.6%
  • Professional services
    $7.51M-12.0%
  • Other non-recurring
    $1.97M-53.0%

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

+2.3%

Avg return

Earnings day

+1.5%

Avg return

5 days after

-0.5%

Avg return

30 days after

52%

12 / 23 earnings

Positive

+20.0%

Q3 2025

Best reaction

-12.9%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.7%+11.3%+6.2%
Q4 2025-4.6%-2.0%-3.3%
Q3 2025+20.0%+15.7%+19.9%
Q2 2025+9.4%+12.9%+20.1%
Q1 2025-11.2%-15.4%-21.6%
Q4 2024-12.9%-18.6%-26.8%
Q3 2024-1.9%-4.1%+11.5%
Q2 2024+17.9%+20.4%+25.6%
Q1 2024-4.4%-5.2%+2.3%
Q4 2023+17.7%+15.7%+19.3%
Q3 2023+6.1%+6.1%+10.1%
Q2 2023+8.4%+4.5%+7.6%
Q1 2023-2.4%-4.2%+7.0%
Q4 2022+14.9%+11.0%+11.6%
Q3 2022-5.9%-8.6%-11.6%
Q2 2021-4.1%-5.0%-7.8%
Q2 2022-5.8%-6.2%-19.4%
Q1 2022+9.1%-0.2%-0.8%
Q4 2019+2.4%+3.8%-18.1%
Q4 2020+2.4%+3.8%-18.1%
Q4 2021+6.3%+1.3%-7.3%
Q3 2021-6.3%-2.5%-18.7%
Q1 2021+0.9%+0.3%+1.1%
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro